| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/13/1997 | WO1997009035A1 Long-lasting composition for rectal administration |
| 03/13/1997 | WO1997009034A1 Pharmaceutical compositions and devices for their administration |
| 03/13/1997 | WO1997009027A1 Cosmetic composition of an alpha or beta-hydroxy acid and a polyvinylpyrrolidone complexing agent |
| 03/13/1997 | WO1997008958A1 Sugar-free dragee-like products |
| 03/13/1997 | WO1997008950A1 System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| 03/13/1997 | WO1997005903A3 Composition for enhanced uptake of polar drugs from the colon |
| 03/13/1997 | WO1997005185A3 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents |
| 03/13/1997 | WO1997004795A3 Pharmaceutical compositions containing cyclosporin or other peptide substances |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | WO1996040784A3 Method of solubilizing, purifying, and refolding protein |
| 03/13/1997 | WO1996040664A3 Preparation of immunogens and other conjugates of drugs |
| 03/13/1997 | WO1996040085A3 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 03/13/1997 | DE19533539A1 O/W-Emulgatoren O / W emulsifiers |
| 03/13/1997 | CA2231442A1 Therapeutic azide compounds |
| 03/13/1997 | CA2231050A1 System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| 03/13/1997 | CA2230557A1 Interactive molecular conjugates |
| 03/13/1997 | CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 03/12/1997 | EP0761690A1 Thermoplastic and biodegradable polysaccharide ester or etherester resulting from the reaction with addition products of maleic acid |
| 03/12/1997 | EP0761319A2 Method for spray coating surfaces of small-size foods or pharmaceutical preparations |
| 03/12/1997 | EP0761234A2 Pharmaceutical combined preparation with ketoprofen |
| 03/12/1997 | EP0761218A1 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate |
| 03/12/1997 | EP0761217A1 Ready-to-use eye lotion containing indomethacin |
| 03/12/1997 | EP0761216A1 Rhodamine 123 compositions and methods for treating prostate cancer |
| 03/12/1997 | EP0761211A1 Sustained release composition |
| 03/12/1997 | EP0761210A2 Process for the manufacture of pharmaceutical preparations with controlled release |
| 03/12/1997 | EP0761207A2 Oral pharmaceutical preparations containing antacids |
| 03/12/1997 | EP0760689A1 Method of manufacturing and storing solutions |
| 03/12/1997 | EP0760683A1 Bile acid conjugates, derivatives thereof with metal complexes and related uses |
| 03/12/1997 | EP0760681A1 Modification of clostridial toxins for use as transport proteins |
| 03/12/1997 | EP0760680A1 Pharmaceutical composition |
| 03/12/1997 | EP0760679A1 Photodynamic conjugates with biocidal properties |
| 03/12/1997 | EP0760677A1 A pharmaceutical preparation comprising glucagon |
| 03/12/1997 | EP0760656A1 Transdermal delivery of anti-epileptic drugs |
| 03/12/1997 | EP0760651A1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels |
| 03/12/1997 | EP0760650A1 Antimicrobial oil-in-water emulsions |
| 03/12/1997 | EP0646006B1 Gastro-protected stable omeprazole compositions in the form of microgranules and process for their production |
| 03/12/1997 | EP0616529B1 Drug formulations for parenteral use |
| 03/12/1997 | EP0409940B1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 03/12/1997 | CN1145080A Block and grate copolymers and method relating thereof |
| 03/12/1997 | CN1145031A Starch-metal complexes for skin and hair |
| 03/12/1997 | CN1145030A Halofantrine free base for the treatment of malaria and compositions |
| 03/12/1997 | CN1144714A Nucleus-shell structure protein high-molecule microball and its manufacturing method |
| 03/12/1997 | CN1144695A Special-used water-solubility (hydrophilicity) excipient for difficult-soluble medicine |
| 03/12/1997 | CN1144677A Flavanolignan preparation, its processing method and pharmaceutical compositions containing them |
| 03/12/1997 | CN1144656A Pharmaceutical compositions containing irbesartan |
| 03/11/1997 | US5610289 Backbone modified oligonucleotide analogues |
| 03/11/1997 | US5610266 Copolymers of trimethylenecarbonate and optionally inactive lactides |
| 03/11/1997 | US5610173 Formulations for lipophilic compounds |
| 03/11/1997 | US5610169 Pharmaceutical Composition containing slightly water-soluble drug |
| 03/11/1997 | US5610147 Heating |
| 03/11/1997 | US5610047 Trehalose |
| 03/11/1997 | US5609882 Antitumor |
| 03/11/1997 | US5609871 Microencapsulating enteric coating |
| 03/11/1997 | US5609869 For use in diagnosis and therapy |
| 03/11/1997 | US5609868 Pharmaceutical compositions comprising hybrid α-interferon |
| 03/11/1997 | US5609867 Polymeric antitumor agents |
| 03/11/1997 | US5609866 Polyvinylpyrrolidone-iodine, nonionic surfactant |
| 03/11/1997 | US5609864 Polyvinylpyrrolidone iodine |
| 03/11/1997 | US5609854 Sunscreen |
| 03/11/1997 | US5609850 Treated apatite particles for ultrasound imaging |
| 03/11/1997 | US5609846 Cytokines, interleukins, reduced side effects |
| 03/11/1997 | US5609590 PH-triggered osmotic bursting delivery devices |
| 03/11/1997 | CA1338980C Bone cement for sustained release of substances |
| 03/09/1997 | CA2184887A1 Pharmaceutical combination preparation comprising ketoprofen |
| 03/06/1997 | WO1997007823A2 Compositions and their uses |
| 03/06/1997 | WO1997007822A1 Method for the production of tablets by pressing and tablets produced by the method |
| 03/06/1997 | WO1997007816A1 Solution containing igf-i |
| 03/06/1997 | WO1997007815A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | WO1997007802A1 Methods and compositions for treating fungal infections in mammals |
| 03/06/1997 | WO1997007794A1 Composition for local anesthesia |
| 03/06/1997 | WO1997007788A2 Composition for sustained release of an agent |
| 03/06/1997 | WO1997007787A1 Oral cyclosporin formulations |
| 03/06/1997 | WO1997007783A1 Embolic material for endovascular occlusion of abnormal vasculature and method of using the same |
| 03/06/1997 | WO1997007771A1 Refreshing compositions |
| 03/06/1997 | WO1997007769A2 Chemical compounds |
| 03/06/1997 | WO1997000275A3 Responsive polymer networks and methods of their use |
| 03/06/1997 | WO1996030049A3 Hapten-carrier conjugates for use in drug-abuse therapy |
| 03/06/1997 | WO1996023479A3 Anti-adhesive active principles |
| 03/06/1997 | CA2230929A1 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | CA2230856A1 Methods and compositions for treating fungal infections in mammals |
| 03/06/1997 | CA2230494A1 Composition for sustained release of an agent |
| 03/06/1997 | CA2230448A1 Composition for local anesthesia |
| 03/06/1997 | CA2230238A1 Method for the production of pressed tablets containing live microorganisms and tablets produced by the method |
| 03/06/1997 | CA2229844A1 Compositions and their uses |
| 03/06/1997 | CA2227040A1 Chemical compounds |
| 03/06/1997 | CA2202887A1 Oral cyclosporin formulations |
| 03/05/1997 | EP0760240A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759939A1 Methods and compositions for the dry powder formulation of interferons |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759784A1 Covalent microparticle-drug conjugates for biological targeting |
| 03/05/1997 | EP0759779A1 Vaccines for oral immunization against infecting agents |
| 03/05/1997 | EP0759775A1 IFN-$g(b) LIQUID FORMULATIONS |
| 03/05/1997 | EP0759773A1 Lacrimal gland specific emulsions for topical application to ocular tissue |
| 03/05/1997 | EP0759769A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1) |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759760A1 Wound healing agent |
| 03/05/1997 | EP0759757A1 Oral liquid alendronate formulations |
| 03/05/1997 | EP0759749A1 Anti-acne compositions |
| 03/05/1997 | EP0759744A1 Narcotic containing aerosol formulation |